Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 18, 2023

BUY
$229.71 - $259.35 $192,726 - $217,594
839 New
839 $207,000
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $183,145 - $215,547
839 New
839 $213,000
Q2 2022

Jul 19, 2022

SELL
$234.74 - $275.42 $64,084 - $75,189
-273 Reduced 24.42%
845 $208,000
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $20,709 - $22,990
-85 Reduced 7.07%
1,118 $297,000
Q4 2021

Jan 10, 2022

SELL
$230.08 - $250.94 $64,882 - $70,765
-282 Reduced 18.99%
1,203 $303,000
Q3 2021

Oct 28, 2021

BUY
$232.72 - $256.47 $1,629 - $1,795
7 Added 0.47%
1,485 $365,000
Q2 2021

Jul 21, 2021

SELL
$232.65 - $254.58 $13,959 - $15,274
-60 Reduced 3.9%
1,478 $359,000
Q1 2021

Apr 20, 2021

BUY
$232.09 - $256.88 $6,266 - $6,935
27 Added 1.79%
1,538 $374,000
Q4 2020

Feb 09, 2021

SELL
$221.92 - $245.94 $40,167 - $44,515
-181 Reduced 10.7%
1,511 $378,000
Q3 2020

Oct 26, 2020

SELL
$215.77 - $276.76 $1,078 - $1,383
-5 Reduced 0.29%
1,692 $394,000
Q1 2020

May 22, 2020

SELL
$195.69 - $279.01 $1,761 - $2,511
-9 Reduced 0.53%
1,697 $390,000
Q4 2019

Jan 29, 2020

SELL
$236.45 - $266.82 $9,458 - $10,672
-40 Reduced 2.29%
1,706 $464,000
Q3 2019

Oct 21, 2019

SELL
$230.58 - $256.08 $5,303 - $5,889
-23 Reduced 1.3%
1,746 $442,000
Q2 2019

Jul 16, 2019

BUY
$217.4 - $246.08 $21,740 - $24,608
100 Added 5.99%
1,769 $446,000
Q1 2019

Apr 26, 2019

SELL
$206.05 - $248.17 $4,327 - $5,211
-21 Reduced 1.24%
1,669 $417,000
Q2 2018

Aug 09, 2018

SELL
$208.1 - $233.85 $9,364 - $10,523
-45 Reduced 2.59%
1,690 $405,000
Q2 2018

Aug 01, 2018

SELL
$208.1 - $233.85 $416 - $467
-2 Reduced 0.12%
1,735 $416,000
Q1 2018

Apr 12, 2018

BUY
$205.46 - $240.27 $32,462 - $37,962
158 Added 10.01%
1,737 $376,000
Q3 2017

Oct 26, 2017

BUY
$186.89 - $198.9 $295,099 - $314,063
1,579
1,579 $309,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Integrated Investment Consultants, LLC Portfolio

Follow Integrated Investment Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.